According to the Centers for Disease Control and Prevention (CDC), more than 6.8 million doses of the Johnson & Johnson (Janssen) vaccine have been administered in the U.S. as of April 12. The CDC and Food and Drug Administration (FDA) in a joint statement on Tuesday, April 13, recommended a pause in the use of Johnson & Johnson's (J&J's) single-dose COVID-19 vaccine out of an abundance of caution. This email was distributed to all Duke Health patients who received a J&J vaccine within three weeks of the update from the CDC and FDA. Uploaded 04.16.21
The information on this site is intended solely for the internal use by Duke University Health System, its medical staff, clinicians and staff and any and all content or services available on or through this website is prohibited to be shared with external parties with the exception of those marked as patient communications that would be disclosed to patients.